MediFind
Condition

Mucopolysaccharidosis Type 2

Active Clinical Trials

Clinical Trial
Other
  • Status: Recruiting
  • Study Type: Other
  • Participants: 28
  • Start Date: October 23, 2019
A Study of Potential Treatment-Responsive Biomarkers in Hunter Syndrome
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 1000
  • Start Date: August 20, 2018
Biomarkers for Hunter Syndrome: An International, Multicenter, Observational, Longitudinal Protocol
Clinical Trial
Drug
  • Status: Active, not recruiting
  • Study Type: Drug
  • Participants: 20
  • Start Date: August 1, 2018
A Phase II/III Study of JR-141 in Patients With Mucopolysaccharidosis II
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 25
  • Start Date: January 19, 2018
Intensive Pharmacovigilance Program for Elaprase (SHP ELA-701)
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 14
  • Start Date: June 5, 2017
Phase 1/2 Study of the Effect of Adalimumab on Physical Function and Musculoskeletal Disease in Mucopolysaccharidosis Types I and II